Skip to content

Ochre Bio

YC W20 · EF 2019 · Active · RNA medicines for liver diseases

Competitors

Adjacent

Also from W20

All of W20

Programs

Programs Ochre Bio went through
ProgramCohortSource
Y CombinatorW20YC Page
Entrepreneur First2019EF Page

About Ochre Bio

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.

YC batch
W20 · Winter 2020
Status, per YC
Active
Category
Other
Team size
50
Location
London, England, United Kingdom; Oxford, England, United Kingdom
Checked
1h ago

YC tags: Biotech, Genomics

Ochre Bio in W20: 228 companies, 29% AI

Ochre Bio: questions

Which YC batch was Ochre Bio in?

Ochre Bio was in Y Combinator's Winter 2020 batch (W20).

Which accelerators did Ochre Bio go through?

Ochre Bio is listed by Y Combinator (W20), Entrepreneur First (2019).

Is Ochre Bio still active?

Y Combinator lists Ochre Bio as active.

Where is Ochre Bio based?

Ochre Bio lists London, England, United Kingdom; Oxford, England, United Kingdom as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.